Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


Connexins and Pannexins: New Insights into Microglial Functions and Dysfunctions.

Gajardo-Gómez R, Labra VC, Orellana JA.

Front Mol Neurosci. 2016 Sep 22;9:86. Review.


Targeting TRPM2 in ROS-Coupled Diseases.

Yamamoto S, Shimizu S.

Pharmaceuticals (Basel). 2016 Sep 7;9(3). pii: E57. doi: 10.3390/ph9030057. Review.


Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signalling.

Plattner H, Verkhratsky A.

Philos Trans R Soc Lond B Biol Sci. 2016 Aug 5;371(1700). pii: 20150419. doi: 10.1098/rstb.2015.0419. Review.


Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma.

Sanchez L, Wang Y, Siegel DS, Wang ML.

J Hematol Oncol. 2016 Jun 30;9(1):51. doi: 10.1186/s13045-016-0283-0. Review.


Preferential Coupling of the NAADP Pathway to Exocytosis in T-Cells.

Davis LC, Platt FM, Galione A.

Messenger (Los Angel). 2015 Jun;4(1):53-66.


New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology.

Roulston A, Shore GC.

Mol Cell Oncol. 2015 Jun 10;3(1):e1052180. doi: 10.1080/23723556.2015.1052180. Review.


CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Camacho-Pereira J, Tarragó MG, Chini CC, Nin V, Escande C, Warner GM, Puranik AS, Schoon RA, Reid JM, Galina A, Chini EN.

Cell Metab. 2016 Jun 14;23(6):1127-39. doi: 10.1016/j.cmet.2016.05.006.


Immuno-targeting the multifunctional CD38 using nanobody.

Li T, Qi S, Unger M, Hou YN, Deng QW, Liu J, Lam CM, Wang XW, Xin D, Zhang P, Koch-Nolte F, Hao Q, Zhang H, Lee HC, Zhao YJ.

Sci Rep. 2016 Jun 2;6:27055. doi: 10.1038/srep27055.


Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression.

López-Abente J, Correa-Rocha R, Pion M.

Front Immunol. 2016 May 19;7:192. doi: 10.3389/fimmu.2016.00192. Review.


Characteristics of chronic lymphocytic leukemia in Senegal.

Sall A, Touré AO, Sall FB, Ndour M, Fall S, Sène A, Faye BF, Seck M, Gadji M, Dièye TN, Mathiot C, Reynaud S, Diop S, Raphaël M.

BMC Hematol. 2016 Apr 23;16:10. doi: 10.1186/s12878-016-0051-y.


Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).

Harlan BA, Pehar M, Sharma DR, Beeson G, Beeson CC, Vargas MR.

J Biol Chem. 2016 May 13;291(20):10836-46. doi: 10.1074/jbc.M115.698779.


Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation.

Gul R, Park DR, Shawl AI, Im SY, Nam TS, Lee SH, Ko JK, Jang KY, Kim D, Kim UH.

PLoS One. 2016 Mar 9;11(3):e0149125. doi: 10.1371/journal.pone.0149125.


Interaction of CD38 Variant and Chronic Interpersonal Stress Prospectively Predicts Social Anxiety and Depression Symptoms Over Six Years.

Tabak BA, Vrshek-Schallhorn S, Zinbarg RE, Prenoveau JM, Mineka S, Redei EE, Adam EK, Craske MG.

Clin Psychol Sci. 2016 Jan 1;4(1):17-27.


Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Drent E, Groen RW, Noort WA, Themeli M, Lammerts van Bueren JJ, Parren PW, Kuball J, Sebestyen Z, Yuan H, de Bruijn J, van de Donk NW, Martens AC, Lokhorst HM, Mutis T.

Haematologica. 2016 May;101(5):616-25. doi: 10.3324/haematol.2015.137620.


Novel Markers to Delineate Murine M1 and M2 Macrophages.

Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, Guerau-de-Arellano M.

PLoS One. 2015 Dec 23;10(12):e0145342. doi: 10.1371/journal.pone.0145342.


NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model.

Horenstein AL, Chillemi A, Quarona V, Zito A, Roato I, Morandi F, Marimpietri D, Bolzoni M, Toscani D, Oldham RJ, Cuccioloni M, Sasser AK, Pistoia V, Giuliani N, Malavasi F.

Cells. 2015 Sep 17;4(3):520-37. doi: 10.3390/cells4030520. Review.


CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.

Karakasheva TA, Waldron TJ, Eruslanov E, Kim SB, Lee JS, O'Brien S, Hicks PD, Basu D, Singhal S, Malavasi F, Rustgi AK.

Cancer Res. 2015 Oct 1;75(19):4074-85. doi: 10.1158/0008-5472.CAN-14-3639.


6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.

Bunaciu RP, Jensen HA, MacDonald RJ, LaTocha DH, Varner JD, Yen A.

PLoS One. 2015 Aug 19;10(8):e0135668. doi: 10.1371/journal.pone.0135668.


Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.

Chiang SH, Harrington WW, Luo G, Milliken NO, Ulrich JC, Chen J, Rajpal DK, Qian Y, Carpenter T, Murray R, Geske RS, Stimpson SA, Kramer HF, Haffner CD, Becherer JD, Preugschat F, Billin AN.

PLoS One. 2015 Aug 19;10(8):e0134927. doi: 10.1371/journal.pone.0134927.


Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives.

Lonial S, Durie B, Palumbo A, San-Miguel J.

Leukemia. 2016 Mar;30(3):526-35. doi: 10.1038/leu.2015.223. Review.

Items per page

Supplemental Content

Support Center